Background Flu-like syndrome (FLS) is a common adverse event experienced by patients with relapsing-remitting multiple sclerosis (RRMS) treated with interferon beta (IFNβ). FLS can lead to poor treatm
IQR, interquartile range; SD, standard deviationMediators were evaluated on Days 0, 3, 7, 14 and 21, except for MIP-3α (Days 0, 3 and 7), estradiol and progesterone (Days 0, 7 and 14). Some subjects w
IntroductionAssessing the impact of migraine preventive treatments on acute medication consumption is important in clinical evaluation. The number of acute medication intakes per each monthly migraine
